Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J U Gutterman

Showing results (111-120 of 333) with videos related to

Pageof 34
Sort By:
Journal of Interferon Research|January 1, 1985
Leukocyte interferon conjugated to beta-D-galactosidase for receptor studies: a preliminary reportB L Maxwell, H A Fritsche, H R Park, et al.
Cancer|October 1, 1991
Development of systemic lupus erythematosus after interferon therapy for chronic myelogenous leukemiaP J Schilling, R Kurzrock, H Kantarjian, et al.
Blood|January 15, 1990
Philadelphia chromosome-negative chronic myelogenous leukemia without breakpoint cluster region rearrangement: a chronic myeloid leukemia with a distinct clinical courseR Kurzrock, H M Kantarjian, M Shtalrid, et al.
International Journal of Cancer|October 15, 1977
Surface immunoglobulins and protease inhibitors of human acute leukemia blastsJ P Cotropia, J U Gutterman, E M Hersh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1985
Antitumor activity of recombinant-derived interferon alpha in metastatic renal cell carcinomaJ R Quesada, A Rios, D Swanson, et al.
The EMBO Journal|October 15, 1996
Inhibition of E2F-mediated transcription by p202D Choubey, S J Li, B Datta, et al.
Hematologic Pathology|January 1, 1988
Tumor necrosis factor and human hematopoiesis: II. Inhibition and mode of action on normal and chronic myelogenous leukemia-derived granulocyte-macrophage progenitor cellsM Beran, S O'Brien, B Andersson, et al.
Journal of the National Cancer Institute|May 1, 1977
The C1q binding test for soluble immune complexes: clinical correlations obtained in patients with cancerR D Rossen, M A Reisberg, E M Hersh, et al.
Annals of the New York Academy of Sciences|January 1, 1976
In vitro and in vivo studies with thymosin in cancer patientsL A Schafer, A L Goldstein, J U Gutterman, et al.
Journal of the National Cancer Institute|May 1, 1976
Evaluation of BCG administered by scarification for immunotherapy of metastatic hepatocarcinoma in the guinea pigM G Hanna, L C Peters, J U Gutterman, et al.
Pageof 34

Showing results (111-120 of 333) with videos related to

Sort By:
Pageof 34
Journal of Interferon Research|January 1, 1985
Leukocyte interferon conjugated to beta-D-galactosidase for receptor studies: a preliminary reportB L Maxwell, H A Fritsche, H R Park, et al.
Cancer|October 1, 1991
Development of systemic lupus erythematosus after interferon therapy for chronic myelogenous leukemiaP J Schilling, R Kurzrock, H Kantarjian, et al.
Blood|January 15, 1990
Philadelphia chromosome-negative chronic myelogenous leukemia without breakpoint cluster region rearrangement: a chronic myeloid leukemia with a distinct clinical courseR Kurzrock, H M Kantarjian, M Shtalrid, et al.
International Journal of Cancer|October 15, 1977
Surface immunoglobulins and protease inhibitors of human acute leukemia blastsJ P Cotropia, J U Gutterman, E M Hersh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1985
Antitumor activity of recombinant-derived interferon alpha in metastatic renal cell carcinomaJ R Quesada, A Rios, D Swanson, et al.
The EMBO Journal|October 15, 1996
Inhibition of E2F-mediated transcription by p202D Choubey, S J Li, B Datta, et al.
Hematologic Pathology|January 1, 1988
Tumor necrosis factor and human hematopoiesis: II. Inhibition and mode of action on normal and chronic myelogenous leukemia-derived granulocyte-macrophage progenitor cellsM Beran, S O'Brien, B Andersson, et al.
Journal of the National Cancer Institute|May 1, 1977
The C1q binding test for soluble immune complexes: clinical correlations obtained in patients with cancerR D Rossen, M A Reisberg, E M Hersh, et al.
Annals of the New York Academy of Sciences|January 1, 1976
In vitro and in vivo studies with thymosin in cancer patientsL A Schafer, A L Goldstein, J U Gutterman, et al.
Journal of the National Cancer Institute|May 1, 1976
Evaluation of BCG administered by scarification for immunotherapy of metastatic hepatocarcinoma in the guinea pigM G Hanna, L C Peters, J U Gutterman, et al.
Pageof 34